tiprankstipranks
Trending News
More News >
Emmaus Life Sciences Inc (EMMA)
OTHER OTC:EMMA
US Market

Emmaus Life Sciences (EMMA) Income Statement

Compare
88 Followers

Emmaus Life Sciences Income Statement

Last quarter (Q3 2025), Emmaus Life Sciences's total revenue was $3.38M, an increase of 2.61% from the same quarter last year. In Q3, Emmaus Life Sciences's net income was $-2.08M. See Emmaus Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 16.65M$ 29.60M$ 18.39M$ 20.61M$ 23.17M
Gross Profit
$ 15.45M$ 28.25M$ 15.80M$ 17.30M$ 20.92M
Operating Expenses
$ 17.35M$ 24.71M$ 22.39M$ 23.43M$ 20.95M
Depreciation and Amortization
$ 22.00K$ 32.00K$ 53.00K$ 59.00K$ 60.00K
EBITDA
$ -910.00K$ 3.62M$ -5.50M$ -12.76M$ 7.02M
Operating Income
$ -1.89M$ 3.54M$ -6.59M$ -6.13M$ -32.00K
Other Income/Expenses
$ -4.53M$ -7.33M$ -3.98M$ -9.79M$ 1.00M
Pretax Income
$ -6.42M$ -3.79M$ -10.56M$ -15.92M$ 973.00K
Net Income
$ -6.45M$ -3.73M$ -10.63M$ -15.95M$ 1.35M
Per Share Metrics
Basic EPS
$ -0.10$ -0.07$ -0.21$ -0.32$ 0.03
Diluted EPS
$ -0.10$ -0.07$ -0.21$ -0.32$ 0.03
Weighted Average Shares Outstanding
63.23M 53.10M 49.44M 49.25M 48.90M
Weighted Average Shares Outstanding (Diluted)
63.23M 53.10M 49.44M 49.25M 48.90M
Currency in USD

Emmaus Life Sciences Earnings and Revenue History